A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma

Takashi Kanematsu, Takashi Matsumata, Ken Shirabe, Keizo Sugimachi, Shigeru Sakamoto, Hajime Nawata, Kanehiro Hasuo, Hiroshi Honda, Kouji Masuda

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors compared the therapeutic results achieved by surgery and TAE in patients with early‐stage HCC and well‐preserved liver function, who were independently treated by two different policies in two separate departments of the same university hospital during the same period. Methods. From 1983 to 1987, 67 patients with HCC underwent hepatic resection at the Department of Surgery of Kyushu University Hospital. During the same period, TAE was the treatment of first choice for HCC, and surgical resection was not chosen in the Department of Internal Medicine of the hospital. TAE was done in 68 patients, who were evaluated blindly in terms of liver function reserve and roentenographic resectability of the tumor. Among the 68 patients, 20 were thought to have anatomically and functionally resectable disease. The therapeutic results obtained in the two groups were compared. Results. The 1‐year, 3‐year, and 5‐year cumulative survival rates for 67 patients undergoing surgery, including one operative death and four hospital deaths, were 89.1%, 74.6%, and 54.6%, respectively. However, the rates were 90.0%, 50.0%, and 17.5%, respectively, for the 20 patients treated with TAE; these differences were statistically significant (P < 0.05). Conclusions. Surgery can offer more favorable results in patients with early‐stage HCC compared with TAE.

Original languageEnglish
Pages (from-to)2181-2186
Number of pages6
JournalCancer
Volume71
Issue number7
DOIs
Publication statusPublished - Jan 1 1993

Fingerprint

Hepatocellular Carcinoma
Liver
Therapeutics
Internal Medicine
Survival Rate
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. / Kanematsu, Takashi; Matsumata, Takashi; Shirabe, Ken; Sugimachi, Keizo; Sakamoto, Shigeru; Nawata, Hajime; Hasuo, Kanehiro; Honda, Hiroshi; Masuda, Kouji.

In: Cancer, Vol. 71, No. 7, 01.01.1993, p. 2181-2186.

Research output: Contribution to journalArticle

Kanematsu, T, Matsumata, T, Shirabe, K, Sugimachi, K, Sakamoto, S, Nawata, H, Hasuo, K, Honda, H & Masuda, K 1993, 'A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma', Cancer, vol. 71, no. 7, pp. 2181-2186. https://doi.org/10.1002/1097-0142(19930401)71:7<2181::AID-CNCR2820710703>3.0.CO;2-3
Kanematsu, Takashi ; Matsumata, Takashi ; Shirabe, Ken ; Sugimachi, Keizo ; Sakamoto, Shigeru ; Nawata, Hajime ; Hasuo, Kanehiro ; Honda, Hiroshi ; Masuda, Kouji. / A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. In: Cancer. 1993 ; Vol. 71, No. 7. pp. 2181-2186.
@article{e811f212edd9438d8f40a7fde939ab2f,
title = "A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma",
abstract = "Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors compared the therapeutic results achieved by surgery and TAE in patients with early‐stage HCC and well‐preserved liver function, who were independently treated by two different policies in two separate departments of the same university hospital during the same period. Methods. From 1983 to 1987, 67 patients with HCC underwent hepatic resection at the Department of Surgery of Kyushu University Hospital. During the same period, TAE was the treatment of first choice for HCC, and surgical resection was not chosen in the Department of Internal Medicine of the hospital. TAE was done in 68 patients, who were evaluated blindly in terms of liver function reserve and roentenographic resectability of the tumor. Among the 68 patients, 20 were thought to have anatomically and functionally resectable disease. The therapeutic results obtained in the two groups were compared. Results. The 1‐year, 3‐year, and 5‐year cumulative survival rates for 67 patients undergoing surgery, including one operative death and four hospital deaths, were 89.1{\%}, 74.6{\%}, and 54.6{\%}, respectively. However, the rates were 90.0{\%}, 50.0{\%}, and 17.5{\%}, respectively, for the 20 patients treated with TAE; these differences were statistically significant (P < 0.05). Conclusions. Surgery can offer more favorable results in patients with early‐stage HCC compared with TAE.",
author = "Takashi Kanematsu and Takashi Matsumata and Ken Shirabe and Keizo Sugimachi and Shigeru Sakamoto and Hajime Nawata and Kanehiro Hasuo and Hiroshi Honda and Kouji Masuda",
year = "1993",
month = "1",
day = "1",
doi = "10.1002/1097-0142(19930401)71:7<2181::AID-CNCR2820710703>3.0.CO;2-3",
language = "English",
volume = "71",
pages = "2181--2186",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma

AU - Kanematsu, Takashi

AU - Matsumata, Takashi

AU - Shirabe, Ken

AU - Sugimachi, Keizo

AU - Sakamoto, Shigeru

AU - Nawata, Hajime

AU - Hasuo, Kanehiro

AU - Honda, Hiroshi

AU - Masuda, Kouji

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors compared the therapeutic results achieved by surgery and TAE in patients with early‐stage HCC and well‐preserved liver function, who were independently treated by two different policies in two separate departments of the same university hospital during the same period. Methods. From 1983 to 1987, 67 patients with HCC underwent hepatic resection at the Department of Surgery of Kyushu University Hospital. During the same period, TAE was the treatment of first choice for HCC, and surgical resection was not chosen in the Department of Internal Medicine of the hospital. TAE was done in 68 patients, who were evaluated blindly in terms of liver function reserve and roentenographic resectability of the tumor. Among the 68 patients, 20 were thought to have anatomically and functionally resectable disease. The therapeutic results obtained in the two groups were compared. Results. The 1‐year, 3‐year, and 5‐year cumulative survival rates for 67 patients undergoing surgery, including one operative death and four hospital deaths, were 89.1%, 74.6%, and 54.6%, respectively. However, the rates were 90.0%, 50.0%, and 17.5%, respectively, for the 20 patients treated with TAE; these differences were statistically significant (P < 0.05). Conclusions. Surgery can offer more favorable results in patients with early‐stage HCC compared with TAE.

AB - Background. Because transcatheter arterial embolization (TAE) has been shown to be effective in patients with unresectable hepatocellular carcinoma (HCC), the question arises whether TAE has an equivalent or superior effect on resectable HCC compared with surgery. To clarify this point, the authors compared the therapeutic results achieved by surgery and TAE in patients with early‐stage HCC and well‐preserved liver function, who were independently treated by two different policies in two separate departments of the same university hospital during the same period. Methods. From 1983 to 1987, 67 patients with HCC underwent hepatic resection at the Department of Surgery of Kyushu University Hospital. During the same period, TAE was the treatment of first choice for HCC, and surgical resection was not chosen in the Department of Internal Medicine of the hospital. TAE was done in 68 patients, who were evaluated blindly in terms of liver function reserve and roentenographic resectability of the tumor. Among the 68 patients, 20 were thought to have anatomically and functionally resectable disease. The therapeutic results obtained in the two groups were compared. Results. The 1‐year, 3‐year, and 5‐year cumulative survival rates for 67 patients undergoing surgery, including one operative death and four hospital deaths, were 89.1%, 74.6%, and 54.6%, respectively. However, the rates were 90.0%, 50.0%, and 17.5%, respectively, for the 20 patients treated with TAE; these differences were statistically significant (P < 0.05). Conclusions. Surgery can offer more favorable results in patients with early‐stage HCC compared with TAE.

UR - http://www.scopus.com/inward/record.url?scp=0027450857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027450857&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19930401)71:7<2181::AID-CNCR2820710703>3.0.CO;2-3

DO - 10.1002/1097-0142(19930401)71:7<2181::AID-CNCR2820710703>3.0.CO;2-3

M3 - Article

VL - 71

SP - 2181

EP - 2186

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -